Oncolytics Biotech Inc. Announces Special Meeting for Jurisdiction Change

Oncolytics Biotech Inc. (Nasdaq: ONCY) has filed a registration statement on Form F-4 with the SEC, including a preliminary management circular/prospectus, for a Special Meeting of Shareholders. The meeting will vote on changing the company's jurisdiction from the Province of Alberta, Canada, to the State of Nevada, USA. This change, expected to occur on January 1, 2026, aims to reduce regulatory burdens and costs associated with dual U.S. and Canadian compliance. The company also plans to continue its existence from Alberta to British Columbia before the domestication. Shareholders will vote on a new incentive award plan as part of the process. The company expects no material changes to its operations or financial results from these changes.